Merck
MRK
#62
Rank
ยฃ186.85 B
Marketcap
ยฃ74.81
Share price
-1.16%
Change (1 day)
-5.78%
Change (1 year)

Merck (MRK) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ58.24 Billion

According to Merck's latest financial reports the company's total liabilities are ยฃ58.24 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Merck - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ56.36 B4.01%
2023-12-31ยฃ54.19 B3.9%
2022-12-31ยฃ52.15 B4.4%
2021-12-31ยฃ49.95 B2.89%
2020-12-31ยฃ48.55 B9.03%
2019-12-31ยฃ44.53 B1.39%
2018-12-31ยฃ43.92 B11.37%
2017-12-31ยฃ39.43 B-11.63%
2016-12-31ยฃ44.62 B16.21%
2015-12-31ยฃ38.40 B21.09%
2014-12-31ยฃ31.71 B-1.89%
2013-12-31ยฃ32.32 B3.11%
2012-12-31ยฃ31.34 B1.12%
2011-12-31ยฃ31.00 B-2.28%
2010-12-31ยฃ31.72 B1%
2009-12-31ยฃ31.41 B76.87%
2008-12-31ยฃ17.75 B27.1%
2007-12-31ยฃ13.97 B11.24%
2006-12-31ยฃ12.56 B-11.45%
2005-12-31ยฃ14.18 B19.03%
2004-12-31ยฃ11.91 B1.05%
2003-12-31ยฃ11.79 B-22.61%
2002-12-31ยฃ15.23 B-4.5%
2001-12-31ยฃ15.95 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
ยฃ86.74 B 48.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ85.17 B 46.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ68.32 B 17.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ58.73 B 0.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ49.53 B-14.96%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
ยฃ45.97 B-21.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ24.45 B-58.01%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
ยฃ46.91 B-19.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
ยฃ24.69 B-57.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ60.40 B 3.71%๐Ÿ‡บ๐Ÿ‡ธ USA